|1.||Hanley, Dan: 3 articles (01/2011 - 01/2006)|
|2.||Serebruany, Victor: 3 articles (01/2011 - 01/2006)|
|3.||Serebruany, Victor L: 3 articles (05/2006 - 04/2003)|
|4.||Hansen, Hans: 2 articles (04/2013 - 04/2013)|
|5.||Parr, Allan T: 2 articles (04/2013 - 04/2013)|
|6.||Benyamin, Ramsin M: 2 articles (04/2013 - 04/2013)|
|7.||Kaye, Alan D: 2 articles (04/2013 - 04/2013)|
|8.||Helm, Standiford: 2 articles (04/2013 - 04/2013)|
|9.||Manchikanti, Laxmaiah: 2 articles (04/2013 - 04/2013)|
|10.||Singh, Vijay: 2 articles (04/2013 - 04/2013)|
01/01/2010 - "Aggrenox is used in the secondary prevention of stroke. "
05/01/2006 - "In short, based on current evidence most guidelines include Aggrenox as a first-line option for secondary prevention of ischemic stroke or TIA, and some recent versions suggest it may be preferable in other clinical scenarios."
05/01/2006 - "Therefore, Aggrenox should be considered a drug of choice to prevent the second stroke. "
09/01/1999 - "Twice-daily oral extended-release dipyridamole/aspirin (400/50 mg/day) was twice as effective as either agent alone in the secondary prevention of stroke in a large clinical trial involving patients with prior stroke or transient ischaemic attack. "
01/01/2004 - "Aggrenox((R)) versus other pharmacotherapy in preventing recurrent stroke."
05/01/2006 - "Eliminating, or at least minimizing, the most frequent side effect, namely transitory headaches at the beginning of therapy with Aggrenox, will benefit patients and increase the use of this agent. "
09/28/2004 - "The authors assessed the prevalence of headaches following extended-release dipyridamole/aspirin combination (DAC), and the efficacy of acetaminophen in the treatment of these headaches. "
|4.||Acute Kidney Injury (Acute Renal Failure)
01/01/2010 - "Acute renal failure, potentially associated with Aggrenox, has been observed in several patients. "
01/01/2010 - "A multi-case report of acute renal failure in patients treated with Aggrenox."
01/01/2010 - "The objective of this study was to determine if Aggrenox was associated with acute renal failure and to determine whether it was acetylsalicylic acid, dipyridamole or the combination that led to decline in renal function. "
|5.||Pathologic Constriction (Stenosis)
01/01/2005 - "Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial."
01/01/2005 - "The Dialysis Access Consortium (DAC) Aggrenox Prevention of Access Stenosis Trial tests the hypothesis that Aggrenox (containing dipyridamole and aspirin) can prevent stenosis and prolong survival of arteriovenous grafts. "
|1.||Aspirin (Acetylsalicylic Acid)
|5.||Platelet Aggregation Inhibitors (Antiplatelet Drugs)
|6.||dipyridamole drug combination aspirin
|9.||Proton Pump Inhibitors
|10.||Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)
|3.||Drug Therapy (Chemotherapy)